Yudai Kudo

Gifu-shi, 5011194, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Cotinine enhances androgen receptor stability and promotes androgen-dependent proliferation in prostate cancer cells: An in vitro study.

Cotinine enhances androgen receptor stability and promotes androgen-dependent proliferation in prostate cancer cells: An in vitro study.

Journal: Archives of biochemistry and biophysics

Published: April 22, 2026

Synthesis of potent human DHRS11 inhibitors and their efficacy against androgen-dependent proliferation and sensitivity to AKT inhibitor Capivasertib of triple-negative breast cancer cells.

Synthesis of potent human DHRS11 inhibitors and their efficacy against androgen-dependent proliferation and sensitivity to AKT inhibitor Capivasertib of triple-negative breast cancer cells.

Journal: European journal of medicinal chemistry

Published: December 10, 2025

Canine aldo-keto reductase 1C3 (AKR1C3/PGFS) exhibits 17β/20α-hydroxysteroid dehydrogenase activity and is inhibited by trilostane.

Canine aldo-keto reductase 1C3 (AKR1C3/PGFS) exhibits 17β/20α-hydroxysteroid dehydrogenase activity and is inhibited by trilostane.

Journal: The Journal of steroid biochemistry and molecular biology

Published: August 25, 2025

Kobochromone A, a polyphenol in Carex kobomugi, suppresses androgen signaling induced by 11-oxygenated androgens and enhances the efficacy of AKT inhibitors in triple-negative breast cancer cells.

Kobochromone A, a polyphenol in Carex kobomugi, suppresses androgen signaling induced by 11-oxygenated androgens and enhances the efficacy of AKT inhibitors in triple-negative breast cancer cells.

Journal: Steroids

Published: July 28, 2025

Gnetin C sensitizes darolutamide-resistant prostate cancer cells by targeting NAD+ and energy metabolism.

Gnetin C sensitizes darolutamide-resistant prostate cancer cells by targeting NAD+ and energy metabolism.

Journal: Biochemical and biophysical research communications

Published: May 12, 2025

Protein Kinase D Regulates Kinesin-Mediated VEGFR2 Trafficking and Influences Retinal Endothelial Permeability.

Protein Kinase D Regulates Kinesin-Mediated VEGFR2 Trafficking and Influences Retinal Endothelial Permeability.

Journal: Traffic (Copenhagen, Denmark)

Published: February 01, 2025

Inhibition of autophagy by Atg7 knockdown enhances chemosensitivity in gemcitabine/paclitaxel-resistant pancreatic cancer MIAPaCa2 cells.

Inhibition of autophagy by Atg7 knockdown enhances chemosensitivity in gemcitabine/paclitaxel-resistant pancreatic cancer MIAPaCa2 cells.

Journal: Journal of biochemistry

Published: December 02, 2024

Docosahexaenoic acid enhances the treatment efficacy for castration-resistant prostate cancer by inhibiting autophagy through Atg4B inhibition.

Docosahexaenoic acid enhances the treatment efficacy for castration-resistant prostate cancer by inhibiting autophagy through Atg4B inhibition.

Journal: Archives of biochemistry and biophysics

Published: July 26, 2024

Inhibition of aldo-keto reductase 1C3 overcomes gemcitabine/cisplatin resistance in bladder cancer.

Inhibition of aldo-keto reductase 1C3 overcomes gemcitabine/cisplatin resistance in bladder cancer.

Journal: Chemico-biological interactions

Published: October 08, 2023

Antiandrogenic Effects of a Polyphenol in Carex kobomugi through Inhibition of Androgen Synthetic Pathway and Downregulation of Androgen Receptor in Prostate Cancer Cell Lines.

Antiandrogenic Effects of a Polyphenol in Carex kobomugi through Inhibition of Androgen Synthetic Pathway and Downregulation of Androgen Receptor in Prostate Cancer Cell Lines.

Journal: International journal of molecular sciences

Published: October 19, 2022

Artepillin C overcomes apalutamide resistance through blocking androgen signaling in prostate cancer cells.

Artepillin C overcomes apalutamide resistance through blocking androgen signaling in prostate cancer cells.

Journal: Archives of biochemistry and biophysics

Published: September 09, 2022

Correction to "Discovery and Structure-Based Optimization of Novel Atg4B Inhibitors for the Treatment of Castration-Resistant Prostate Cancer".

Correction to "Discovery and Structure-Based Optimization of Novel Atg4B Inhibitors for the Treatment of Castration-Resistant Prostate Cancer".

Journal: Journal of medicinal chemistry

Published: May 27, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026